Target intelligence / Profile preview

Karyopherin subunit alpha 2 pseudogene 3 (KPNA2P3)

Target
KPNA2P3
Molecular classification
Pseudogene
01

Overview

KPNA2P3 (Karyopherin subunit alpha 2 pseudogene 3) is classified as a pseudogene, a DNA sequence derived from the parental gene encoding karyopherin subunit alpha 2, but typically nonfunctional due to accumulated mutations. There is no evidence it encodes a protein, acts as a receptor, enzyme, or other typical drug target. As with other pseudogenes, it might theoretically exhibit regulatory RNA functions, but no specific data support such activity for KPNA2P3. It is not considered an actionable molecule for direct therapeutic modulation. The parental gene (KPNA2, karyopherin subunit alpha 2) encodes a protein implicated in nuclear transport, but KPNA2P3 itself is a noncoding pseudogene version with no reported biological target properties. The naming convention (KPNA2P3) follows standard nomenclature for pseudogenes (parent gene + "P" + ordinal number). General functions of pseudogenes (not specific to KPNA2P3) include acting as regulatory RNAs, miRNA decoys, or sources of processed transcripts, but these specific roles have not been established for KPNA2P3. No evidence in available genetic, functional, or clinical databases supports KPNA2P3 as a functional receptor, enzyme, transporter, or any druggable protein target.

Other names
HGNC: 52870NCBI Gene: 109286552Ensembl: ENSG00000266820
02

Biological functions

None as a protein or enzymePossible regulatory roles in gene expression as observed for other pseudogenes, but no documented function specific to KPNA2P3.
03

Disease associations

None directly establishedGeneral pseudogene literature suggests some pseudogenes have roles in gene regulation affecting diseases such as cancer or immune response, but no direct association for KPNA2P3.

Beyond the preview

Go deeper on Karyopherin subunit alpha 2 pseudogene 3 (KPNA2P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Karyopherin subunit alpha 2 pseudogene 3 (KPNA2P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call